A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer Cells

Breast cancer is the most frequently diagnosed life-threatening cancer in women. As a result, there is a critical need for the development of a safe and effective drug therapy for its treatment. Curcumin, a secondary metabolite isolated from <i>Curcuma longa</i>, has been shown to exhibi...

Full description

Bibliographic Details
Main Authors: Ivana Todorovska, Katerina Dragarska, Jane Bogdanov
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Chemistry Proceedings
Subjects:
Online Access:https://www.mdpi.com/2673-4583/12/1/5
_version_ 1797595542223585280
author Ivana Todorovska
Katerina Dragarska
Jane Bogdanov
author_facet Ivana Todorovska
Katerina Dragarska
Jane Bogdanov
author_sort Ivana Todorovska
collection DOAJ
description Breast cancer is the most frequently diagnosed life-threatening cancer in women. As a result, there is a critical need for the development of a safe and effective drug therapy for its treatment. Curcumin, a secondary metabolite isolated from <i>Curcuma longa</i>, has been shown to exhibit an impressively broad range of pharmacological effects. Despite its powerful interaction with a diverse set of cellular targets, curcumin has several drawbacks that limit its potential as a therapeutic agent. One of the most common approaches to overcoming these limitations is the design and synthesis of novel curcumin analogs. This study was conducted in support of the ongoing search for new molecules that are effective enough for the treatment of triple-negative breast cancer while causing only minor side effects. Hence, several symmetric monocarbonyl analogs of curcumin with cyclopentanone, cyclohexanone and 4-piperidone as the central core were synthesized via a Claisen–Schmidt condensation reaction. Their structures were identified by measuring the melting points, as well as using FTIR and UV/VIS spectroscopic techniques. To assess the cytotoxic activities of the analogs against MDA-MB-231 breast cancer cells and to identify the significant structural features responsible for these molecules’ potency, combined 2D- and 3D-quantitative structure–activity relationship (QSAR) models were developed. The generated QSAR models demonstrated acceptable internal validation, as well as good external predictive capacity, indicating that they can be used to design similar compounds. These results suggest that the synthesized candidate drugs have promising cytotoxic potential against MDA-MB-231 cancer cells and should be further investigated both in vitro and in vivo.
first_indexed 2024-03-11T02:38:03Z
format Article
id doaj.art-9415a05f7e41460893f350e0c93ca5b9
institution Directory Open Access Journal
issn 2673-4583
language English
last_indexed 2024-03-11T02:38:03Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Chemistry Proceedings
spelling doaj.art-9415a05f7e41460893f350e0c93ca5b92023-11-18T09:47:39ZengMDPI AGChemistry Proceedings2673-45832022-11-01121510.3390/ecsoc-26-13572A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer CellsIvana Todorovska0Katerina Dragarska1Jane Bogdanov2Institute of Chemistry, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, P.O. Box 162, 1000 Skopje, North MacedoniaInstitute of Chemistry, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, P.O. Box 162, 1000 Skopje, North MacedoniaInstitute of Chemistry, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, P.O. Box 162, 1000 Skopje, North MacedoniaBreast cancer is the most frequently diagnosed life-threatening cancer in women. As a result, there is a critical need for the development of a safe and effective drug therapy for its treatment. Curcumin, a secondary metabolite isolated from <i>Curcuma longa</i>, has been shown to exhibit an impressively broad range of pharmacological effects. Despite its powerful interaction with a diverse set of cellular targets, curcumin has several drawbacks that limit its potential as a therapeutic agent. One of the most common approaches to overcoming these limitations is the design and synthesis of novel curcumin analogs. This study was conducted in support of the ongoing search for new molecules that are effective enough for the treatment of triple-negative breast cancer while causing only minor side effects. Hence, several symmetric monocarbonyl analogs of curcumin with cyclopentanone, cyclohexanone and 4-piperidone as the central core were synthesized via a Claisen–Schmidt condensation reaction. Their structures were identified by measuring the melting points, as well as using FTIR and UV/VIS spectroscopic techniques. To assess the cytotoxic activities of the analogs against MDA-MB-231 breast cancer cells and to identify the significant structural features responsible for these molecules’ potency, combined 2D- and 3D-quantitative structure–activity relationship (QSAR) models were developed. The generated QSAR models demonstrated acceptable internal validation, as well as good external predictive capacity, indicating that they can be used to design similar compounds. These results suggest that the synthesized candidate drugs have promising cytotoxic potential against MDA-MB-231 cancer cells and should be further investigated both in vitro and in vivo.https://www.mdpi.com/2673-4583/12/1/5curcuminmonocarbonyl analogsbreast cancerQSARMDA-MB 231FTIR
spellingShingle Ivana Todorovska
Katerina Dragarska
Jane Bogdanov
A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer Cells
Chemistry Proceedings
curcumin
monocarbonyl analogs
breast cancer
QSAR
MDA-MB 231
FTIR
title A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer Cells
title_full A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer Cells
title_fullStr A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer Cells
title_full_unstemmed A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer Cells
title_short A Combined 2D- and 3D-QSAR Study, Design and Synthesis of Some Monocarbonyl Curcumin Analogs as Potential Inhibitors of MDA-MB-231 Breast Cancer Cells
title_sort combined 2d and 3d qsar study design and synthesis of some monocarbonyl curcumin analogs as potential inhibitors of mda mb 231 breast cancer cells
topic curcumin
monocarbonyl analogs
breast cancer
QSAR
MDA-MB 231
FTIR
url https://www.mdpi.com/2673-4583/12/1/5
work_keys_str_mv AT ivanatodorovska acombined2dand3dqsarstudydesignandsynthesisofsomemonocarbonylcurcuminanalogsaspotentialinhibitorsofmdamb231breastcancercells
AT katerinadragarska acombined2dand3dqsarstudydesignandsynthesisofsomemonocarbonylcurcuminanalogsaspotentialinhibitorsofmdamb231breastcancercells
AT janebogdanov acombined2dand3dqsarstudydesignandsynthesisofsomemonocarbonylcurcuminanalogsaspotentialinhibitorsofmdamb231breastcancercells
AT ivanatodorovska combined2dand3dqsarstudydesignandsynthesisofsomemonocarbonylcurcuminanalogsaspotentialinhibitorsofmdamb231breastcancercells
AT katerinadragarska combined2dand3dqsarstudydesignandsynthesisofsomemonocarbonylcurcuminanalogsaspotentialinhibitorsofmdamb231breastcancercells
AT janebogdanov combined2dand3dqsarstudydesignandsynthesisofsomemonocarbonylcurcuminanalogsaspotentialinhibitorsofmdamb231breastcancercells